This international consensus statement provides expert guidance on the diagnosis, risk stratification, and management of inherited primary arrhythmia syndromes.
Answers are grounded in this paper and cite their sources.
Standardizes care for inherited primary arrhythmia syndromes; extends prior consensus with updated risk stratification and management recommendations.
This international consensus statement is the collaborative effort of three medical societies representing electrophysiology in North America, Europe, and Asian-Pacific area: the Heart Rhythm Society (HRS), the European Heart Rhythm Association (EHRA), and the Asia Pacific Heart Rhythm Society. The objective of the consensus document is to provide clinical guidance for diagnosis, risk stratification, and management of patients affected by inherited primary arrhythmia syndromes. It summarizes the opinion of the international writing group members based on their own experience and on a general review of the literature with respect to the clinical data on patients affected by channelopathies. This document does not address the indications of genetic testing in patients affected by inherited arrhythmias and their family members. Diagnostic, prognostic, and therapeutic implications of the results of genetic testing are also not included in this document because this topic has been covered by a recent publication1 coauthored by some of the contributors of this consensus document, and it remains the reference text on this topic. Guidance for the evaluation of patients with idiopathic ventricular fibrillation, sudden arrhythmic death …
No takes yet. Share an insight, caveat, or question.
Priori et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: